Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

ANASTASIS BIOTEC LIMITED

Company number 10502511

Follow this company File for this company
Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
05 Nov 2020 AA Unaudited abridged accounts made up to 31 December 2019
28 Oct 2020 SH01 Statement of capital following an allotment of shares on 27 October 2020
  • GBP 32,229.3
29 Sep 2020 MA Memorandum and Articles of Association
29 Sep 2020 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
29 Jul 2020 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES13 ‐ Increase auth cap 01/07/2020
  • RES12 ‐ Resolution of varying share rights or name
  • RES10 ‐ Resolution of allotment of securities
29 Jun 2020 SH01 Statement of capital following an allotment of shares on 21 February 2020
  • GBP 32,229.3
29 Nov 2019 CS01 Confirmation statement made on 28 November 2019 with updates
06 Sep 2019 AA Unaudited abridged accounts made up to 31 December 2018
26 May 2019 TM01 Termination of appointment of Alexandra Anna Obolensky Hudson as a director on 23 May 2019
21 May 2019 AP01 Appointment of Dr Mahendra Persaud Deonarain as a director on 19 April 2019
15 May 2019 AP01 Appointment of Dr. Alexandra Anna Obolensky Hudson as a director on 17 April 2019
28 Nov 2018 CS01 Confirmation statement made on 28 November 2018 with no updates
02 Sep 2018 TM01 Termination of appointment of Michael Kyriakides as a director on 2 September 2018
31 Aug 2018 AA Micro company accounts made up to 31 December 2017
22 Jan 2018 AP01 Appointment of Mr Michael Kyriakides as a director on 19 January 2018
29 Nov 2017 CS01 Confirmation statement made on 28 November 2017 with updates
09 Nov 2017 SH01 Statement of capital following an allotment of shares on 26 October 2017
  • GBP 22,500
14 Jun 2017 SH02 Sub-division of shares on 25 May 2017
08 Jun 2017 AP01 Appointment of Mr Laurence John Cohen as a director on 25 May 2017
08 Jun 2017 AA01 Current accounting period extended from 30 November 2017 to 31 December 2017
07 Jun 2017 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
10 Apr 2017 CH01 Director's details changed for Professor Agamemnon Antoniou Epenetos on 31 March 2017
29 Nov 2016 NEWINC Incorporation
  • MODEL ARTICLES ‐ Model articles adopted

Statement of capital on 2016-11-29
  • GBP 1,000